BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 20233087)

  • 1. Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands.
    Ali A; Stefàno E; De Castro F; Ciccarella G; Rovito G; Marsigliante S; Muscella A; Benedetti M; Fanizzi FP
    Chemistry; 2024 May; ():e202401064. PubMed ID: 38703115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of Group IVB metallocene polyethers containing dienestrol to arrest the growth of selected cancer cell lines.
    Roner MR; Carraher CE; Shahi K; Ashida Y; Barot G
    BMC Cancer; 2009 Oct; 9():358. PubMed ID: 19811643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine.
    Abdullah A; Huq F; Chowdhury A; Tayyem H; Beale P; Fisher K
    BMC Chem Biol; 2006 Mar; 6():3. PubMed ID: 16533399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic Acid-based Electrochemical Sensors Facilitate the Study of DNA Binding by Platinum (II)-based Antineoplastics.
    Wu Y; Arroyo-Currás N
    Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202312402. PubMed ID: 38227790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands.
    Gümüş F; Eren G; Açik L; Celebi A; Oztürk F; Yilmaz S; Sagkan RI; Gür S; Ozkul A; Elmali A; Elerman Y
    J Med Chem; 2009 Mar; 52(5):1345-57. PubMed ID: 19220055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands.
    Ozçelik AB; Utku S; Gümüş F; Keskin AÇ; Açık L; Yılmaz S; Ozgüngör A
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):413-8. PubMed ID: 22299582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.
    Utku S; Ozçelik AB; Gümüş F; Yılmaz S; Arsoy T; Açık L; Celebi Keskin A
    J Pharm Pharmacol; 2014 Nov; 66(11):1593-605. PubMed ID: 25109360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands.
    Utku S; Gumus F; Tezcan S; Serin MS; Ozkul A
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):502-8. PubMed ID: 20233087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.
    Reedijk J
    Metallomics; 2012 Jul; 4(7):628-32. PubMed ID: 22488113
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.